Company profile for Terns Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Terns Pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver disease and cancer.nThe company combines expertise in disease biology and medicinal chemistry with a capital-efficient drug discovery model and extensive clinical development capabilities in China to advance its growing pipeline of drugs that are optimized against ...
Terns Pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver disease and cancer.\nThe company combines expertise in disease biology and medicinal chemistry with a capital-efficient drug discovery model and extensive clinical development capabilities in China to advance its growing pipeline of drugs that are optimized against clinically-validated targets.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
TERNS PHARMACEUTICALS, INC.\n1810 GATEWAY DRIVE, SUITE 320\nSAN MATEO, CA 9440...
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/11/3204296/0/en/Terns-Announces-Closing-of-Public-Offering-of-Common-Stock-Including-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html

GLOBENEWSWIRE
11 Dec 2025
Terns Announces Proposed Public Offering
Terns Announces Proposed Public Offering

09 Dec 2025

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2025/12/09/3202173/0/en/Terns-Announces-Proposed-Public-Offering.html

GLOBENEWSWIRE
09 Dec 2025

https://www.globenewswire.com/news-release/2025/11/14/3188615/0/en/Terns-Pharmaceuticals-to-Participate-in-the-Jefferies-Global-Healthcare-Conference-in-London.html

GLOBENEWSWIRE
14 Nov 2025

https://www.globenewswire.com/news-release/2025/11/10/3185044/0/en/Terns-Pharmaceuticals-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Updates.html

GLOBENEWSWIRE
10 Nov 2025

https://www.globenewswire.com/news-release/2025/11/04/3180842/0/en/Terns-Pharmaceuticals-Reports-Inducement-Grants-to-New-Employees-Under-Nasdaq-Listing-Rule-5635-C-4.html

GLOBENEWSWIRE
04 Nov 2025

https://www.globenewswire.com/news-release/2025/11/03/3179399/0/en/Terns-Announces-Abstract-with-Positive-Clinical-Data-for-TERN-701-in-Relapsed-Refractory-CML-Selected-for-Oral-Presentation-at-67th-ASH-Annual-Meeting.html

GLOBENEWSWIRE
03 Nov 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty